$56.44
0.440.79%
At close: May 8, 5:00 PM EST
$56.44
N/A
After Hours: May 8, 4:00 PM EST
Xenon Pharmaceuticals Inc Earnings Estimates
XENENASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 2 days agoClick to view the webcast
Xenon Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:XENE
In the most recent quarter (Q1), Xenon Pharmaceuticals reported EPS of $-1.17, beating estimates of $-1.19 by 0.02%. Revenue came in at $0.00, missing the estimate of $3.80M by 1.00%.
Over the last 4 quarters, Xenon Pharmaceuticals has averaged an EPS surprise of 0.05% and a revenue surprise of 1.00%.
Earnings Date
May 7
EPS
$-1.170
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Xenon Pharmaceuticals Earnings History
Analyze the earnings history of Xenon Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Xenon Pharmaceuticals (XENE) Earnings Per Share
The chart below shows Xenon Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Xenon Pharmaceuticals (XENE) Revenue
The chart below shows Xenon Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?
Xenon Pharmaceuticals (XENE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Xenon Pharmaceuticals (NASDAQ:XENE)?
Xenon Pharmaceuticals (XENE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 7, 2026 for Q1 and the Actual EPS was $-1.17, which beat the estimate of $-1.19.
What were Xenon Pharmaceuticals’s (NASDAQ:XENE) revenues?
Xenon Pharmaceuticals (XENE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 7, 2026 for Q1 and the Actual Revenue was $0.00, which missed the estimate of $3.80M.
